Depomed to Present at the Morgan Stanley Global Healthcare Conference
September 05 2017 - 3:01PM
Depomed, Inc. (NASDAQ:DEPO) today announced that its senior
management will participate in a fireside chat at the 2017 Morgan
Stanley Global Healthcare Conference scheduled for 4:40 pm ET (1:40
am PT) on Tuesday, September 12, 2017 in New York, New York.
The fireside chat will be webcast live and may be accessed via
the Investor Relations page of the Depomed website at
www.depomed.com. A recording of the event will be archived
for 30 days on the company's website.
About Depomed
Depomed is a leading specialty pharmaceutical company focused on
enhancing the lives of the patients, families, physicians,
providers and payors we serve through commercializing innovative
products for pain and neurology related disorders. Depomed markets
six medicines with areas of focus that include mild to severe acute
pain, moderate to severe chronic pain, neuropathic pain, migraine
and breakthrough cancer pain. Depomed is headquartered in Newark,
California. To learn more about Depomed, visit www.depomed.com.
Investor and Media Contact:
Christopher Keenan
VP, Investor Relations and Corporate Communications
510-744-8000
ckeenan@depomed.com
Depomed, Inc. (delisted) (NASDAQ:DEPO)
Historical Stock Chart
From Apr 2024 to May 2024
Depomed, Inc. (delisted) (NASDAQ:DEPO)
Historical Stock Chart
From May 2023 to May 2024
Real-Time news about Depomed, Inc. (delisted) (NASDAQ): 0 recent articles
More News Articles